Allied World Assurance (AWH) Appoints Celeste Fralick to its Board
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Aspira Women’s Health Announces Appointment of Celeste Fralick, Ph.D., to its Board of Directors
February 28, 2022 8:14 AM ESTAUSTIN, Texas, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Aspira Womens Health Inc. (Nasdaq: AWH), a bioanalytical-based womens health company, today announced the appointment of Celeste Fralick, Ph.D., to its Board of Directors, effective February 23, 2022.
Dr. Fralick is an accomplished executive with over four decades of data strategy experience. She brings to the Board a broad background in technology and specifically healthcare in several markets with both customer and industry-facing experience. She has expertise in statistics, cybersecurity, system engineering, disability analyses, risk management, operations, quality systems, global regulatory affairs, clinical management, biotechnology,... More



